强生在宾夕法尼亚州投资10亿美元建设新细胞疗法基地。
J&J pours $1B into new cell therapy site in Pennsylvania
生物技术与制药领域的最新动态
J&J pours $1B into new cell therapy site in Pennsylvania
T cells store lipids and die in rheumatoid arthritis joints
Giant DNA viruses encode a hallmark translation initiation complex of eukaryotic life
Cell cycle-dependent cues regulate temporal patterning of the Drosophila central brain neural stem cells
Cell therapy company hopes to end Tokyo biotech IPO drought with $92M offering
Extracellular matrix sensing regulates intratumoral heterogeneity of autophagic flux
A single-cell time-series atlas of endothelial cell embryonic development
Selecting the optimal cell therapy manufacturing platform
Deep neural networks to register and annotate cells in moving and deforming nervous systems
SETDB1 enables development beyond cleavage stages by extinguishing the MERVL-driven two-cell totipotency transcriptional program in the mouse embryo
CLIM-TIME identifies metastatic microenvironment modulators for T cell therapy response
Persistent T cell activation and cytotoxicity against glioblastoma following single oncolytic virus treatment in a clinical trial
Tumor, immune and neural cells are involved in cancer cachexia
Cdc42 interacts with chaperone Ydj1 to enhance its stability and partitioning during asymmetric cell division and aging in yeast
Lilly’s $2.4B bet on off-the-shelf cell therapy is part of a wider Big Pharma shift
Single-cell atlas of AML reveals age-related gene regulatory networks in t(8;21) AML
Planetary microbiome structure and generalist-driven gene flow across disparate habitats
CUL5 E3 ubiquitin ligase regulates the evasion of bladder cancer cells to CD8+ T cell-mediated killing by inhibiting autophagy
Navigating the complexities of Cell and Gene Therapy supply chains
Mouse skeletal muscle satellite cells co-opt the tenogenic gene Scleraxis to instruct regeneration